ProfileGDS4718 / 223041_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 65% 85% 59% 64% 66% 63% 66% 64% 65% 65% 64% 62% 66% 67% 67% 64% 61% 62% 60% 65% 65% 65% 66% 62% 61% 68% 66% 66% 71% 67% 72% 65% 68% 64% 80% 61% 65% 62% 88% 66% 62% 77% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6682567
GSM549102patient 115, normal, homogenized [OPG study]6.4955665
GSM549104patient 119, normal, homogenized [OPG study]8.4891185
GSM549108patient 138, normal, homogenized [OPG study]6.0663859
GSM549119patient 077, normal, homogenized [OPG study]6.3847164
GSM549133patient 032, cancer, homogenized [OPG study]6.5494566
GSM549139patient 042, cancer, homogenized [OPG study]6.3592963
GSM549099patient 107, normal, homogenized [OPG study]6.5272566
GSM549109patient 139, normal, homogenized [OPG study]6.4288364
GSM549110patient 046, normal, homogenized [OPG study]6.4608765
GSM549114patient 063, normal, homogenized [OPG study]6.4679465
GSM549122patient 082, normal, homogenized [OPG study]6.3940964
GSM549134patient 033, cancer, homogenized [OPG study]6.2366962
GSM549136patient 036, cancer, homogenized [OPG study]6.5975266
GSM549140patient 044, cancer, homogenized [OPG study]6.667767
GSM549111patient 047, normal, homogenized [OPG study]6.6583467
GSM549113patient 057, normal, homogenized [OPG study]6.4006464
GSM549132patient 031, cancer, homogenized [OPG study]6.2124261
GSM549137patient 038, cancer, homogenized [OPG study]6.2822862
GSM549142patient 047, cancer, homogenized [OPG study]6.1898560
GSM549100patient 110, normal, homogenized [OPG study]6.4162265
GSM549107patient 135, normal, homogenized [OPG study]6.4662265
GSM549115patient 068, normal, homogenized [OPG study]6.4786465
GSM549116patient 072, normal, homogenized [OPG study]6.5333166
GSM549120patient 078, normal, homogenized [OPG study]6.2292162
GSM549131patient 030, cancer, homogenized [OPG study]6.1878561
GSM549118patient 074, normal, homogenized [OPG study]6.6790168
GSM549129patient 027, cancer, homogenized [OPG study]6.6108866
GSM549123patient 088, normal, homogenized [OPG study]6.5339966
GSM549124patient 006, cancer, homogenized [OPG study]6.9150371
GSM549126patient 015, cancer, homogenized [OPG study]6.6276467
GSM549128patient 025, cancer, homogenized [OPG study]7.0962172
GSM549103patient 117, normal, homogenized [OPG study]6.4790465
GSM549117patient 073, normal, homogenized [OPG study]6.6931768
GSM549138patient 041, cancer, homogenized [OPG study]6.4206764
GSM549141patient 045, cancer, homogenized [OPG study]7.9411680
GSM549130patient 028, cancer, homogenized [OPG study]6.1962261
GSM549101patient 111, normal, homogenized [OPG study]6.472565
GSM549105patient 128, normal, homogenized [OPG study]6.2703462
GSM549106patient 134, normal, homogenized [OPG study]9.0626288
GSM549112patient 048, normal, homogenized [OPG study]6.566266
GSM549125patient 011, cancer, homogenized [OPG study]6.2440562
GSM549127patient 024, cancer, homogenized [OPG study]7.6167677
GSM549135patient 035, cancer, homogenized [OPG study]6.8514669